Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
Effect of PLK1 inhibition on cisplatin-resistant gastric cancer cells
Zihao Chen1,2, Yanling Chai3, Ting Zhao1
1Graduate School of Hebei Medical University, Shijiazhuang, China.
Objective:
This study aims to investigate the effect of polo-like kinase 1 (PLK1) inhibition on cisplatin (DDP)-resistant gastric cancer (GC) cells.
Methods:
The transcriptional level of PLK1 was measured by quantitative reverse-transcription polymerase chain reaction. Expressions of PLK1 and its downstream mediators as well as autophagy-related protein LC3 I/LC3 II were detected by western blot. An 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 5-ethynyl-2'-deoxyuridine immunofluorescent staining were conducted to evaluate the cell viability and replication activity separately. Flow cytometry was carried out to determine the cell cycle status. The GFP-LC3 vector contributed toward tracking the formation and aggregation of autophagosomes.
Results:
Drug-resistant SGC-7901/DDP cells showed insignificant changes in all phases after DDP treatment, including DNA replication, cell proliferation, cell cycle, and apoptosis, whereas DDP could significantly improve the autophagy level of SGC-7901/DDP as well as PLK1expression. By downregulating the expression of PLK1, both BI2536 andsi-PLK1 enhanced SGC-7901/DDP sensitivity to DDP, suppressing the proliferation and autophagy as well as improving the apoptosis rate. PLK1 inhibition also resulted in the repression of cell division regulators CDC25C and cyclin B1.
Conclusion:
Together, our experimental results illustrated that the DDP resistance of GC cells might be associated with the aberrant overexpression of PLK1. PLK1 inhibition, including si-PLK1 and BI2536 treatment, could restore the chemosensitivity of drug-resistant SGC-7901/DDP cells and enhance the efficacy of DDP, revealing the potential value of PLK1 inhibition in GC chemotherapy.
Insights
Polo-like kinase 1 (PLK1) overexpression drives cisplatin resistance in gastric cancer (GC). Inhibiting PLK1 restores sensitivity to chemotherapy, offering a potential new treatment strategy for GC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Gastric cancer (GC) exhibits resistance to cisplatin (DDP) chemotherapy.
- Polo-like kinase 1 (PLK1) is implicated in cancer cell proliferation and survival.
Purpose of the Study:
- To investigate the role of PLK1 in DDP-resistant GC cells.
- To evaluate the therapeutic potential of PLK1 inhibition in overcoming DDP resistance.
Main Methods:
- Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and western blot were used to measure PLK1 expression.
- Cell viability, proliferation, cell cycle, and apoptosis were assessed using MTT assays, EdU staining, and flow cytometry.
- Autophagosome formation was tracked using a GFP-LC3 vector.
Main Results:
- DDP-resistant GC cells (SGC-7901/DDP) showed increased autophagy and PLK1 expression.
- PLK1 inhibition (using BI2536 or si-PLK1) resensitized cells to DDP, suppressed proliferation and autophagy, and enhanced apoptosis.
- PLK1 inhibition downregulated cell division regulators CDC25C and cyclin B1.
Conclusions:
- Aberrant PLK1 overexpression contributes to DDP resistance in GC.
- Targeting PLK1 can restore chemosensitivity in DDP-resistant GC cells, highlighting its potential as a therapeutic target in GC chemotherapy.
More Related Videos
08:42Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Published on: July 19, 2019
09:24Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
Related Concept Videos
Treatment Resistant Cancers
Feedback Inhibition
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastric Emptying
Gastric Phase of Digestion
When food enters the stomach, it stretches the stomach walls and activates stretch receptors. This triggers local reflexes of the enteric nervous system, mediated through the myenteric plexus. These...
Resistivity